Currently out of the existing stock ratings of Patrick Wood, 100 are a HOLD (58.14%), 61 are a BUY (35.47%), 11 are a SELL (6.4%).

Patrick Wood

Work Performance Price Targets & Ratings Chart

Analyst Patrick Wood, currently employed at MORGAN STANLEY, carries an average stock price target met ratio of 57.53% that have a potential upside of 9.03% achieved within 103 days.

Patrick Wood’s has documented 347 price targets and ratings displayed on 27 stocks. The coverage is on Healthcare, Financial Services sectors.

Most recent stock forecast was given on PODD, Insulet at 06-Aug-2026.

Wall Street Analyst Patrick Wood

Analyst best performing recommendations are on SGHT (SIGHT SCIENCES).
The best stock recommendation documented was for TNDM (TANDEM DIABETES CARE) at 11/10/2025. The price target of $17 was fulfilled within 1 day with a profit of $0.63 (3.85%) receiving and performance score of 38.49.

Average potential price target upside

of $42.82 (17.42%) on PODD (INSULET).
of $26.85 (36.18%) on MDT (MEDTRONIC PLC).
of $11.39 (5.42%) on STE (STERIS PLC).

ABT Abbott Laboratories ALC Alcon AG BAX Baxter International BDX Becton Dickinson and Company BLCO Bausch + Lomb Corp BSX Boston Scientific Corp COO The Cooper Companies Common Stock DXCM DexCom EW Edwards Lifesciences Corp GEHC GE HealthCare Technologies GKOS Glaukos Corp ISRG Intuitive Surgical MDT Medtronic PLC PODD Insulet PRCT Procept Biorobotics Corp RXST Rxsight SGHT Sight Sciences SI Silvergate Capital SOLV Solventum Corp. STAA STAAR Surgical Company STE STERIS plc SYK Stryker TFX Teleflex TMDX TransMedics Group TMO Thermo Fisher Scientific TNDM Tandem Diabetes Care ZBH Zimmer Biomet Holdings

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Patrick Wood (MORGAN STANLEY)